UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $361.03 Million Stake in Mettler-Toledo International, Inc. $MTD

Key Points

• UBS Asset Management has increased its stake in Mettler-Toledo International by 42.0%, owning approximately $361 million worth of the company's shares as of its latest SEC filing.
• Multiple institutional investors have also adjusted their holdings in Mettler-Toledo, including D. E. Shaw & Co. which saw a remarkable 212.0% increase in its position during the last quarter.
• Mettler-Toledo reported earnings of $10.09 per share for the last quarter, exceeding analyst expectations and reflecting a year-over-year revenue growth of 3.9%.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 42.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 305,722 shares of the medical instruments supplier's stock after purchasing an additional 90,395 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 1.47% of Mettler-Toledo International worth $361,030,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Captrust Financial Advisors raised its position in shares of Mettler-Toledo International by 11.6% during the 4th quarter. Captrust Financial Advisors now owns 656 shares of the medical instruments supplier's stock worth $802,000 after buying an additional 68 shares in the last quarter. Cetera Investment Advisers raised its holdings in Mettler-Toledo International by 8.7% during the fourth quarter. Cetera Investment Advisers now owns 1,075 shares of the medical instruments supplier's stock worth $1,315,000 after purchasing an additional 86 shares in the last quarter. D. E. Shaw & Co. Inc. lifted its position in Mettler-Toledo International by 212.0% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 10,192 shares of the medical instruments supplier's stock worth $12,472,000 after purchasing an additional 6,925 shares during the period. Focus Partners Wealth boosted its stake in Mettler-Toledo International by 8.5% during the 4th quarter. Focus Partners Wealth now owns 1,721 shares of the medical instruments supplier's stock valued at $2,106,000 after purchasing an additional 135 shares in the last quarter. Finally, Graham Capital Management L.P. acquired a new position in shares of Mettler-Toledo International during the 4th quarter valued at $683,000. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded up $5.20 during midday trading on Tuesday, reaching $1,265.33. The stock had a trading volume of 26,234 shares, compared to its average volume of 168,407. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01. The firm has a market cap of $26.07 billion, a price-to-earnings ratio of 32.04, a PEG ratio of 3.78 and a beta of 1.37. The firm's fifty day simple moving average is $1,260.42 and its two-hundred day simple moving average is $1,184.76.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the prior year, the company earned $9.65 earnings per share. The company's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,389,588.55. This represents a 5.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 in the last 90 days. 0.77% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on MTD shares. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Citigroup boosted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Bank of America raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Finally, Evercore ISI dropped their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of "Moderate Buy" and a consensus price target of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.